Published in Nucleic Acids Res on October 01, 2003
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nat Chem Biol (2011) 1.31
Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA. RNA (2004) 1.11
Probing Na(+)-induced changes in the HIV-1 TAR conformational dynamics using NMR residual dipolar couplings: new insights into the role of counterions and electrostatic interactions in adaptive recognition. Biochemistry (2007) 1.05
Identification of neomycin B-binding site in T box antiterminator model RNA. Bioorg Med Chem (2008) 0.94
Fluorescence of covalently attached pyrene as a general RNA folding probe. Nucleic Acids Res (2006) 0.91
Using an emissive uridine analogue for assembling fluorescent HIV-1 TAR constructs. Tetrahedron (2007) 0.85
Reversible site-specific tagging of enzymatically synthesized RNAs using aldehyde-hydrazine chemistry and protease-cleavable linkers. Nucleic Acids Res (2007) 0.85
Direct observation of aminoglycoside-RNA binding by localized surface plasmon resonance spectroscopy. Anal Chem (2013) 0.76
Electrostatic interactions in aminoglycoside-RNA complexes. Biophys J (2015) 0.75
Utilizing Intrinsic Properties of Polyaniline to Detect Nucleic Acid Hybridization through UV-Enhanced Electrostatic Interaction. Biomacromolecules (2015) 0.75
Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity. Q Rev Biophys (1978) 9.44
Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (1987) 8.96
Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem (1994) 4.70
Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol Pharmacol (1965) 4.45
Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res (1996) 2.55
Antibiotic inhibition of group I ribozyme function. Nature (1991) 2.44
DNA aggregation induced by polyamines and cobalthexamine. J Biol Chem (1996) 2.36
Kinetic and thermodynamic characterization of the R17 coat protein-ribonucleic acid interaction. Biochemistry (1983) 2.07
Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J (1991) 1.96
Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell (1993) 1.90
Pentalysine-deoxyribonucleic acid interactions: a model for the general effects of ion concentrations on the interactions of proteins with nucleic acids. Biochemistry (1980) 1.78
Activation of HIV transcription by Tat. Curr Opin Genet Dev (1992) 1.57
Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem Biol (1998) 1.52
Structure, conformation, and dynamics of bioactive oligosaccharides: theoretical approaches and experimental validations. Chem Rev (2000) 1.48
Enhanced RNA binding of dimerized aminoglycosides. Bioorg Med Chem (1999) 1.37
Inhibition of the hammerhead ribozyme by neomycin. RNA (1995) 1.31
Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer. Structure (1999) 1.29
Deciphering RNA recognition: aminoglycoside binding to the hammerhead ribozyme. Chem Biol (1998) 1.26
Thermodynamics of aminoglycoside-rRNA recognition: the binding of neomycin-class aminoglycosides to the A site of 16S rRNA. Biochemistry (2002) 1.25
Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B. J Biol Chem (2000) 1.20
Strategies for the Design of Drugs Targeting RNA and RNA-Protein Complexes. Angew Chem Int Ed Engl (2000) 1.19
Hairpin ribozyme cleavage catalyzed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acids Res (1998) 1.17
Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance. J Am Chem Soc (1997) 1.16
2'-Pyrene modified oligonucleotide provides a highly sensitive fluorescent probe of RNA. Nucleic Acids Res (1999) 1.16
Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry (1998) 1.16
Docking of cationic antibiotics to negatively charged pockets in RNA folds. J Med Chem (1999) 1.15
Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci U S A (1999) 1.09
RNA as a drug target: chemical, modelling, and evolutionary tools. Curr Opin Biotechnol (1998) 1.07
RNA tertiary folding monitored by fluorescence of covalently attached pyrene. Biochemistry (1999) 1.07
Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorg Med Chem (1997) 1.02
Rational ligand design for RNA: the role of static structure and conformational flexibility in target recognition. Biochimie (2002) 1.01
HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics. J Biol Chem (2002) 0.98
Electron paramagnetic resonance dynamic signatures of TAR RNA-small molecule complexes provide insight into RNA structure and recognition. Biochemistry (2002) 0.96
tRNA(Phe) binds aminoglycoside antibiotics. Bioorg Med Chem (1999) 0.96
5'-bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure. Nucleic Acids Res (2001) 0.92
Multiple metal ions drive DNA association by PvuII endonuclease. Biochemistry (2002) 0.89
RNA as a target for drug design, the example of Tat-TAR interaction. Curr Top Med Chem (2002) 0.86
Ion-exchange chromatography of aminoglycoside antibodies. Methods Enzymol (1975) 0.86
On the kinetics of distamycin binding to its target sites on duplex DNA. Proc Natl Acad Sci U S A (2000) 0.86
Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex. J Med Chem (1998) 0.81
Fluorescent analogs of biomolecular building blocks: design, properties, and applications. Chem Rev (2010) 2.16
Antibiotics that target protein synthesis. Wiley Interdiscip Rev RNA (2010) 1.43
Simple fluorescent pyrimidine analogues detect the presence of DNA abasic sites. J Am Chem Soc (2005) 1.42
Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine. J Am Chem Soc (2003) 1.31
Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions. Biochemistry (2006) 1.28
Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A (2008) 1.26
Fluorescent pyrimidine ribonucleotide: synthesis, enzymatic incorporation, and utilization. J Am Chem Soc (2007) 1.23
Emissive RNA alphabet. J Am Chem Soc (2011) 1.22
A boost for the emerging field of RNA nanotechnology. ACS Nano (2011) 1.17
Nanopore analysis of individual RNA/antibiotic complexes. ACS Nano (2011) 1.14
Conformational constraint as a means for understanding RNA-aminoglycoside specificity. J Am Chem Soc (2005) 1.11
FRET enabled real time detection of RNA-small molecule binding. J Am Chem Soc (2009) 1.11
Donor/acceptor interactions in systematically modified Ru(II)-Os(II) oligonucleotides. J Am Chem Soc (2002) 1.11
Molecular recognition of RNA by neomycin and a restricted neomycin derivative. Angew Chem Int Ed Engl (2005) 1.10
RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element. Biochemistry (2003) 1.08
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem (2007) 1.07
Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors. Biopolymers (2003) 1.05
A highly fluorescent nucleoside analog based on thieno[3,4-d]pyrimidine senses mismatched pairing. Org Biomol Chem (2008) 1.03
Polarity of major grooves explored by using an isosteric emissive nucleoside. Chembiochem (2008) 1.02
Furan Decorated Nucleoside Analogues as Fluorescent Probes: synthesis, photophysical evaluation and site-specific incorporation. Tetrahedron (2007) 1.02
A highly emissive fluorescent nucleoside that signals the activity of toxic ribosome-inactivating proteins. Angew Chem Int Ed Engl (2008) 1.02
On the electronic structure of ethidium. Chemistry (2005) 0.99
An emissive C analog distinguishes between G, 8-oxoG, and T. Org Lett (2009) 0.97
Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis. J Biol Chem (2008) 0.96
Antibiotic selectivity for prokaryotic vs. eukaryotic decoding sites. Chem Commun (Camb) (2010) 0.96
Guanidinoneomycin B recognition of an HIV-1 RNA helix. Chembiochem (2008) 0.96
To D or not to D? On estimating the microenvironment polarity of biomolecular cavities. Org Biomol Chem (2007) 0.96
Emissive nucleosides as molecular rotors. Chemphyschem (2010) 0.95
Fluorescent ribonucleoside as a FRET acceptor for tryptophan in native proteins. J Am Chem Soc (2010) 0.94
Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies. J Med Chem (2006) 0.94
Cooperative, heparan sulfate-dependent cellular uptake of dimeric guanidinoglycosides. Chembiochem (2010) 0.93
Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery. J Am Chem Soc (2007) 0.92
Selectively guanidinylated aminoglycosides as antibiotics. ChemMedChem (2012) 0.91
Synthesis and enzymatic incorporation of a fluorescent pyrimidine ribonucleotide. Nat Protoc (2007) 0.91
RNA-selective modification by a platinum(II) complex conjugated to amino- and guanidinoglycosides. Angew Chem Int Ed Engl (2005) 0.91
Ru(II) and Os(II) nucleosides and oligonucleotides: synthesis and properties. J Am Chem Soc (2002) 0.91
Monitoring translation with modified mRNAs strategically labeled with isomorphic fluorescent guanosine mimetics. ACS Chem Biol (2013) 0.91
Mechanical properties of DNA-like polymers. Nucleic Acids Res (2013) 0.89
Guanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes. Mol Ther (2010) 0.89
A tale of two targets: differential RNA selectivity of nucleobase-aminoglycoside conjugates. Chembiochem (2006) 0.89
Synthesis and site-specific incorporation of a simple fluorescent pyrimidine. Nat Protoc (2007) 0.89
Eilatin Ru(II) complexes display anti-HIV activity and enantiomeric diversity in the binding of RNA. Chembiochem (2002) 0.87
Fluorescent nucleoside analogue displays enhanced emission upon pairing with guanine. Org Biomol Chem (2010) 0.87
Enzymatic interconversion of isomorphic fluorescent nucleosides: adenosine deaminase transforms an adenosine analogue into an inosine analogue. Angew Chem Int Ed Engl (2013) 0.86
Aggregation-mediated macromolecular uptake by a molecular transporter. ACS Chem Biol (2013) 0.86
Isomorphic emissive GTP surrogate facilitates initiation and elongation of in vitro transcription reactions. J Am Chem Soc (2014) 0.86
Conquering 2-aminopurine's deficiencies: highly emissive isomorphic guanosine surrogate faithfully monitors guanosine conformation and dynamics in DNA. J Am Chem Soc (2015) 0.85
Using an emissive uridine analogue for assembling fluorescent HIV-1 TAR constructs. Tetrahedron (2007) 0.85
Redox-active metal-containing nucleotides: synthesis, tunability, and enzymatic incorporation into DNA. J Am Chem Soc (2002) 0.84
Fluorescent 1,10-phenanthroline-containing oligonucleotides distinguish between perfect and mismatched base pairing. Org Lett (2002) 0.84
Enzymatic incorporation of emissive pyrimidine ribonucleotides. Chem Asian J (2009) 0.84
Polyamide platinum anticancer complexes designed to target specific DNA sequences. Inorg Chem (2006) 0.83
Modified 6-aza uridines: highly emissive pH-sensitive fluorescent nucleosides. Chemphyschem (2012) 0.83
Simple conversion of aromatic amines into azides. Org Lett (2003) 0.83
Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules. Biochemistry (2003) 0.83
Design, synthesis, and spectroscopic properties of extended and fused pyrrolo-dC and pyrrolo-C analogs. Org Lett (2012) 0.82
Multisensing emissive pyrimidine. Chemphyschem (2011) 0.82
Dual emission from a family of conjugated dinuclear Ru(II) complexes. J Am Chem Soc (2005) 0.82
The DNA and RNA specificity of eilatin Ru(II) complexes as compared to eilatin and ethidium bromide. Nucleic Acids Res (2003) 0.81
Polymyxins and analogues bind to ribosomal RNA and interfere with eukaryotic translation in vitro. Chembiochem (2013) 0.81
Cleavage of RNA oligonucleotides by aminoglycosides. Org Biomol Chem (2008) 0.81
Photodimerizable ditopic ligand. Org Lett (2006) 0.81
New macrocyclic terbium(III) complex for use in RNA footprinting experiments. J Am Chem Soc (2009) 0.81
Synthesis and stability of exocyclic triazine nucleosides. Org Biomol Chem (2005) 0.81
Defining the molecular forces that determine the impact of neomycin on bacterial protein synthesis: importance of the 2'-amino functionality. Antimicrob Agents Chemother (2007) 0.80
Synthesis of N-methylpyrrole and N-methylimidazole amino acids suitable for solid-phase synthesis. J Org Chem (2004) 0.80
Synthesis, photophysical properties, and nucleic acid binding of phenanthridinium derivatives based on ethidium. Bioorg Med Chem (2003) 0.80
On guanidinium and cellular uptake. J Org Chem (2014) 0.79
Cellular activity of siRNA oligonucleotides containing synthetic isomorphic nucleoside surrogates. Chem Commun (Camb) (2015) 0.79
Extended ethidium bromide analogue as a triple helix intercalator: synthesis, photophysical properties and nucleic acids binding. Chem Commun (Camb) (2006) 0.79
Binding of HIV-1 TAR mRNA to a peptide nucleic acid oligomer and its conjugates with metal-ion-binding multidentate ligands. J Biol Inorg Chem (2008) 0.79
RuII complexes of "large-surface" ligands. Angew Chem Int Ed Engl (2002) 0.79
Two-photon-induced fluorescence of isomorphic nucleobase analogs. Chemphyschem (2014) 0.78
MDDD, a 4,9-diazapyrenium derivative, is selectively toxic to glioma cells by inducing growth arrest at G0/G1 independently of p53. Invest New Drugs (2006) 0.78
Visibly emissive and responsive extended 6-aza-uridines. Org Lett (2014) 0.78
Bifacial nucleoside as a surrogate for both T and A in duplex DNA. J Am Chem Soc (2011) 0.78
Ruthenium complexes that break the rules: structural features controlling dual emission. J Am Chem Soc (2007) 0.78
Genetic alphabetic order: what came before A? Org Biomol Chem (2005) 0.77
Refining the genetic alphabet: a late-period selection pressure? Astrobiology (2012) 0.77
Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria. ChemMedChem (2014) 0.76
Model systems: how chemical biologists study RNA. Curr Opin Chem Biol (2009) 0.76
Direct observation of aminoglycoside-RNA binding by localized surface plasmon resonance spectroscopy. Anal Chem (2013) 0.76
Oligodeoxynucleotides containing multiple thiophene-modified isomorphic fluorescent nucleosides. J Org Chem (2013) 0.76
Macromolecular uptake of alkyl-chain-modified guanidinoglycoside molecular transporters. Chembiochem (2014) 0.76
Citric acid and the RNA world. Angew Chem Int Ed Engl (2014) 0.75
Application of Surface Click Reactions to Localized Surface Plasmon Resonance (LSPR) Biosensing. Chemistry (2017) 0.75
Symmetrical dinuclear complexes with high DNA affinity based on [Ru(dpq)2(phen)]2+. Chem Commun (Camb) (2004) 0.75
Alkyne-containing chelating ligands: synthesis, properties and metal coordination of 1,2-di(quinolin-8-yl)ethyne. Dalton Trans (2006) 0.75
Emissive synthetic cofactors: An isomorphic, isofunctional and re-sponsive NAD+ analogue. J Am Chem Soc (2017) 0.75